Jorge Garcia, PharmD, MS, MHA, MBA, FACHE, Baptist Health South Florida, spoke about his panel held at the recent Institute for Value-Based Medicine® that The American Journal of Managed Care® cohosted with Providence Health System.
Jorge Garcia, PharmD, MS, MHA, MBA, FACHE, assistant vice president of system oncology and infusion pharmacy services, Baptist Health South Florida, spoke about his panel on ambulatory drug infusion that was featured at the recent Institute for Value-Based Medicine (IVBM) held in Newport Beach, California, cohosted by The American Journal of Managed Care and Providence Health System.
Transcript
What were you most looking forward to at the IVBM conference in Newport Beach?
I think what I'm most excited about is just coming together with colleagues to understand how they're working through different challenges and opportunities in their respective facilities and what I can bring back to my home institution to continue to advance health care.
What can attendees expect from your presentation on ambulatory drug infusion?
Over the years, I have sometimes gotten phone calls about patients who need nononcology infusion therapy. Sometimes the providers will call directly and they would ask me, "Help me find a share to infuse this patient, otherwise I may need to bring the patient through the Emergency Department. Or even worse, I may need to get the patient admitted."
As we know, that's not ideal, using those acute health care resources for an infusion that could otherwise be provided to the patient in the ambulatory setting. So with that vision in mind, we have put in practice a new service line that looks at ambulatory infusions for patients. Now we've operated the centers for 3 years, and we've learned a lot along the way; we've definitely opened access. We would love to share our experiences, our successes, and the challenges that we continue to work through to ensure that there is good access to nononcology infusion medicines in our community.
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Organizational Factors Associated With Variation in Primary Care Providers in ACOs
April 8th 2025A higher percentage of accountable care organization (ACO) primary care providers was associated with physician leadership, upside financial risk, and financial compensation of physicians tied to performance measures.
Read More